Home / INDRAMEDCO.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does INDRAMEDCO.NS make money? Does INDRAMEDCO.NS have pricing power? What's the Earnings Whisper? Will INDRAMEDCO.NS profit more as the business scales? What is INDRAMEDCO.NS's management track record? Is INDRAMEDCO.NS's current price justified?

Indraprastha Medical Corporation Limited

₹320.05 -$130.50 (-28.96%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹321.45

Day Range

₹317.05₹323

Year Range

₹317.05₹640.85

Market Cap

29.34B

AVG Volume

278.22K

Trailing/Forward PE

15.6/13.12

PEG ratio

1.69

Dividend Yield

1.25%

Next Earnings Date

2026-10-30

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

INDRAMEDCO.NS Revenue (INR) by year
Period	Revenue (INR)
2026	14.83B
2025	13.56B
2024	12.45B
2023	10.99B
2022	8.62B
2021	5.96B
2020	7.97B
2019	7.6B
2018	7.48B
2017	7.59B

Net Income (INR) · A

INDRAMEDCO.NS Net Income (INR) by year
Period	Net Income (INR)
2026	1.84B
2025	1.61B
2024	1.24B
2023	861.5M
2022	586.35M
2021	23.29M
2020	436.24M
2019	284.16M
2018	211.03M
2017	262.44M

Operating Income (INR) · A

INDRAMEDCO.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	2.23B
2025	2B
2024	1.57B
2023	1.21B
2022	851.31M
2021	69.47M
2020	544.36M
2019	524.49M
2018	428.12M
2017	497.88M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Indraprastha Medical Corporation Limited

Video analysis: INDRAMEDCO.NS

News: INDRAMEDCO.NS

Similar companies